On May 16, Benchmark lowered the price target on Alibaba from $190 to $176, keeping a Buy rating on the…
Read More »BABA
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2025 investor letter. A…
Read More »